Year: 2025

VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce that it has engaged 45 Degrees, Inc. (“45 Degrees”) and Investment Publishing LLC (“Investment Publishing”) to provide digital marketing and investor awareness services on behalf of Treatment as further described below. 45 Degrees: 45 Degrees of Cheyenne, WY, has been engaged by Treatment for a six-month term commencing immediately to provide advertising services including Google Ads, social media and video interview distribution (the “Marketing Engagement”). The Marketing Engagement was entered into on July 18, 2025, in consideration of a total fee of USD $180,000 to be paid in two equal installments: USD $90,000 on signing and USD $90,000 due 10 weeks after the marketing...

Singapore, July 18, 2025 (GLOBE NEWSWIRE) — Origin Investment Corp I (the “Company”), a newly organized special purpose acquisition company, today announced that, the underwriters of its recently completed initial public offering of units, which closed on July 3, 2025, have exercised in full their option to purchase an additional 900,000 units. The additional units were sold at a price to the public of $10.00, before underwriting discounts. The issuance and sale of these additional units closed today. ThinkEquity acted as the sole book-running manager for the offering. A registration statement on Form S-1 (File No. 333-284189) relating to the units was filed with the Securities and Exchange Commission (“SEC”) and became effective on July 1, 2025. This offering was made only by means of a prospectus. Copies of the final prospectus...

DUBLIN, Ohio, July 18, 2025 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced the closing of its previously announced public offering of an aggregate of 13,333,334 shares of its common stock, together with Series A-1 warrants to purchase up to 13,333,334 shares of common stock and Series A-2 warrants to purchase up to 13,333,334 shares of common stock, at a combined public offering price of $0.15 per share and accompanying warrants. The Series A-1 warrants and the Series A-2 warrants have an exercise price of $0.15 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the warrants. The Series A-1 warrants will expire five years from the date of stockholder...

Will Request Hearing DALLAS, July 18, 2025 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that on July 16, 2025, the Company was notified by The Nasdaq Stock Market LLC (“Nasdaq”) that, due to its continued non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and the delay in the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025 with the Securities and Exchange Commission, in contravention of Nasdaq’s periodic reporting requirement set forth in Nasdaq Listing Rule 5250(c)(1), the Company’s securities...

Optiva is in negotiations with its existing noteholders and certain third parties regarding a potential transaction that would result in the exchange of Optiva’s outstanding notes for a combination of shares and new notes of a proforma merged strategic third party (a “Potential Transaction“). Optiva will continue operating its business as usual, fulfilling all ongoing commitments to customers, employees, and suppliers. Based on the proposals received to date, Optiva’s common shareholders are expected to receive nominal consideration for their shares in connection with any Potential Transaction.TORONTO, July 18, 2025 (GLOBE NEWSWIRE) — Optiva Inc. (TSX: OPT) (“Optiva” or the “Company“), a leader in powering the telecom industry with cloud-native billing, charging and revenue management...

MIAMI, July 18, 2025 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces that it has entered into an additional amendment to its previously disclosed Limited Waiver Agreement with the holders of a majority of its senior secured notes (the “Majority Holders”). This latest amendment extends the temporary waiver period to July 25, 2025, providing the Company with further time and flexibility to continue ongoing negotiations with its senior lenders and to further pursue strategic options to strengthen its capital structure. As previously disclosed, under the Limited Waiver Agreement, the Majority Holders have provided a waiver of certain events of default related to the Company’s delay in filing...

TORONTO, July 18, 2025 (GLOBE NEWSWIRE) — Further to its March 31, 2025 announcement welcoming Antoine De Vuyst as Chief Technology Officer (“CTO”) and lead designer of the forthcoming Digital Gold Platform on Bitcoin, Matador Technologies Inc. (TSXV: MATA, OTCQB: MATAF, FSE: IU3) (“Matador” or the “Company”) is providing the following summary of Mr. De Vuyst’s consulting agreement (the “Agreement“), as requested by the TSX Venture Exchange (the “TSXV”). Under the Agreement, which took effect March 1, 2025, Mr. De Vuyst serves as CTO on a month-to-month basis and devotes the time required to meet Matador’s product-development milestones. As consideration for his services as CTO, Mr. De Vuyst will receive:C$5,000 per month in common shares of the Company, calculated quarterly, using the 30-day volume-weighted average...

HOUSTON, TX, July 18, 2025 (GLOBE NEWSWIRE) — Pyrophyte Acquisition Corp. II (NYSE: PAII) (the “Company”) today announced the closing of its initial public offering of 17,500,000 units at a public offering price of $10.00 per unit. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. The units are listed on the New York Stock Exchange (the “NYSE”) and commenced trading under the ticker symbol “PAII.U” on July 17, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be listed on NYSE under the symbols “PAII” and “PAII WS,” respectively. Concurrently with the closing of the initial public offering, the Company...

ATLANTA, July 18, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray” or the “Company”) (NYSE: GTN) today announced that it has (i) increased the aggregate commitments under its revolving credit facility (the “Revolving Credit Facility”) by $50 million, resulting in aggregate commitments under the Revolving Credit Facility of $750 million, and (ii) extended the maturity date of the Revolving Credit Facility from December 1, 2027 to December 1, 2028.  In connection with the amendment and the previously announced offering of $900 million aggregate principal amount of 9.625% senior secured second lien notes due 2032 (the “Notes”), there is $700 million of undrawn availability under the Revolving Credit Facility (excluding approximately $8 million of outstanding letters of credit). The Revolving Credit Facility is available on a revolving...

CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of July 17, 2025, the Compensation Committee of the Board of Directors granted Qing Zuraw, M.D., the Company’s Chief Development Officer, 4,373,040 stock options and 937,080 restricted stock units (“RSUs”) in connection with the commencement of her employment. The foregoing stock option and RSU awards were granted as a material inducement to employment with Vor Bio in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Vor Biopharma Inc. 2023 Inducement Plan (the “Inducement Plan”). The stock options have a ten-year term and an exercise price of $2.38 per share, which is equal to the closing price of Vor Bio’s...